Rocky Mountain Spotted Fever
- 1 May 1970
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 125 (5) , 879-882
- https://doi.org/10.1001/archinte.1970.00310050117015
Abstract
Prior to the introduction of broadspectrum antibiotics, Rocky Mountain spotted fever was a devastating disease. Subsequently, the mortality has dropped from 20% 1-3 to approximately 5%,2,4 and the illness is frequently considered to be benign if appropriately treated. The fact that the generalized vasculitis of Rocky Mountain spotted fever can be life-threatening in spite of prompt therapy with chloramphenicol or one of the tetracyclines is not always recognized. The following cases illustrate the complications of this vascular damage and emphasize the importance of appropriate management and therapy based upon an understanding of the pathophysiologic derangements. Patient Summaries Patient 1. —A 35-year-old white man was hospitalized in June 1967 with a four-day illness characterized by chills, photophobia, headache, lassitude, nausea, vomiting, and diarrhea. A history of tick bites during a recent vacation on an Oklahoma farm was elicited. On admission he had a temperature of 105 F (40.6 C) andThis publication has 7 references indexed in Scilit:
- Hypofibrinogenemia in Rocky Mountain Spotted FeverNew England Journal of Medicine, 1964
- Thrombocytopenia in Rocky Mountain Spotted FeverPublished by American Medical Association (AMA) ,1963
- Rickettsial Diseases in the United StatesMedical Clinics of North America, 1959
- STATUS OF THE RICKETTSIOSES IN THE UNITED STATESAnnals of Internal Medicine, 1959
- PATHOGENESIS OF CIRCULATORY FAILURE IN ROCKY MOUNTAIN SPOTTED FEVERArchives of internal medicine (1908), 1949
- A NEW APPROACH TO BASIC SUPPORTIVE THERAPY IN ROCKY MOUNTAIN SPOTTED FEVERSouthern Medical Journal, 1945
- THE TREATMENT OF ROCKY MOUNTAIN SPOTTED FEVERJAMA, 1944